Pentagon’s annual testosterone screening draws skepticism from medical professionals
BLUF – The article highlights growing skepticism among endocrinologists and other medical experts about the Pentagon’s new policy requiring annual testosterone screening for service members age 30 and older, arguing that broad population screening is not supported by current clinical guidelines and could lead to unnecessary treatment, infertility, cardiovascular risks, and other adverse effects if hormone therapy is prescribed without clear medical indications. For Navy Medicine, the debate underscores the need for evidence-based implementation, careful endocrine evaluation, and standardized clinical protocols to ensure any readiness-focused hormone screening program balances operational goals with patient safety and accepted medical practice.